Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A04491 | 33597924 | Front Endocrinol (Lausanne) | The Role of Lipophagy in the Development and Treatment of Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A04492 | 33597157 | Gut | Safety and efficacy of hydrothermal duodenal mucosal resurfacing in patients with type 2 diabetes: the randomised, double-blind, sham-controlled, multicentre REVITA-2 feasibility trial. | 2021 | Details |
| A04493 | 33597074 | Clin Ther | Advances in the Epidemiology, Diagnosis, and Management of Pediatric Fatty Liver Disease. | 2021 | Details |
| A04494 | 33596964 | J Med Case Rep | Hemochromatosis, alcoholism and unhealthy dietary fat: a case report. | 2021 | Details |
| A04495 | 33596938 | J Transl Med | Insulin treatment improves liver histopathology and decreases expression of inflammatory and fibrogenic genes in a hyperglycemic, dyslipidemic hamster model of NAFLD. | 2021 | Details |
| A04497 | 33596132 | Metab Syndr Relat Disord | When They're Done Growing, Don't Forget They May Still Need Growth Hormone. | 2021 | Details |
| A04498 | 33596128 | Arch Physiol Biochem | Folic acid ameliorates palmitate-induced inflammation through decreasing homocysteine and inhibiting NF-κB pathway in HepG2 cells. | 2021 | Details |
| A04499 | 33596054 | Anal Chem | CD36 as a Molecular Target of Functional DNA Aptamer NAFLD01 Selected against NAFLD Cells. | 2021 | Details |
| A04501 | 33595790 | Obes Surg | Outcomes of Bariatric Surgery in Patients with Liver Cirrhosis: a Systematic Review. | 2021 | Details |
| A04502 | 33595214 | Isr Med Assoc J | The Impact of Ramadan Fasting on Fatty Liver Disease Severity: A Retrospective Case Control Study from Israel. | 2021 | Details |
| A04504 | 33594747 | Hepatol Res | Artificial intelligence/neural network system for the screening of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. | 2021 | Details |
| A04505 | 33594733 | J Magn Reson Imaging | Quantification of the Hemodynamic Changes of Cirrhosis with Free-Breathing Self-Navigated MRI. | 2021 | Details |
| A04506 | 33594581 | Diabetes Ther | Efficacy and Safety of Luseogliflozin in Patients with Type 2 Diabetes Complicated by Hepatic Dysfunction: A Single-Site, Single-Arm, Open-Label, Exploratory Trial. | 2021 | Details |
| A04507 | 33594319 | Am J Transl Res | miR-122-5p/KIF5B/AMPK/AKT regulatory network regulates the progression of NAFLD. | 2021 | Details |
| A04508 | 33594198 | Sci Rep | Hepatic connective tissue growth factor expression and regulation differ between non-steatotic and non-alcoholic steatotic livers from brain-dead donor. | 2021 | Details |
| A04509 | 33593749 | BMJ Open Diabetes Res Care | Comparing the effects of tofogliflozin and pioglitazone in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus (ToPiND study): a randomized prospective open-label controlled trial. | 2021 | Details |
| A04510 | 33593250 | Curr Pharm Des | Prevalence of Non-coronary Heart Disease in Patients with Familial Hypercholesterolemia: An Analysis from the HELLAS-FH. | 2021 | Details |
| A04511 | 33593235 | Expert Rev Pharmacoecon Outcomes Res | Direct medical costs of non-alcoholic fatty liver disease in Catalonia at the hospital level: a retrospective multicenter study. | 2021 | Details |
| A04512 | 33592910 | Medicine (Baltimore) | Association of non-alcoholic fatty liver disease and all-cause mortality in hospitalized cardiovascular disease patients: A systematic review and meta-analysis. | 2021 | Details |
| A04513 | 33592427 | Clin Res Hepatol Gastroenterol | Integrated expression profiles of mRNA and miRNA in a gerbil model of fatty liver fibrosis treated with exenatide. | 2021 | Details |
| A04514 | 33592199 | Life Sci | Non-alcoholic fatty liver disease: An overview of risk factors, pathophysiological mechanisms, diagnostic procedures, and therapeutic interventions. | 2021 | Details |
| A04515 | 33591626 | J Cell Mol Med | Mesenchymal stromal cells protect hepatocytes from lipotoxicity through alleviation of endoplasmic reticulum stress by restoring SERCA activity. | 2021 | Details |
| A04516 | 33590934 | Liver Int | Prevalence of NAFLD, MAFLD and associated advanced fibrosis in the contemporary United States population. | 2021 | Details |
| A04517 | 33590598 | Liver Int | Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis in five European countries in 2018: A cost-of-illness analysis. | 2021 | Details |
| A04518 | 33590347 | J Nat Med | Dehydroabietic acid improves nonalcoholic fatty liver disease through activating the Keap1/Nrf2-ARE signaling pathway to reduce ferroptosis. | 2021 | Details |
| A04520 | 33588566 | Arch Iran Med | Association between Dietary Patterns and Non-alcoholic Fatty Liver Disease: Results from a Case-Control Study. | 2021 | Details |
| A04521 | 33588102 | Mol Metab | Stress kinases in the development of liver steatosis and hepatocellular carcinoma. | 2021 | Details |
| A04522 | 33588049 | Free Radic Biol Med | Influence of cardiometabolic comorbidities on myocardial function, infarction, and cardioprotection: Role of cardiac redox signaling. | 2021 | Details |
| A04524 | 33587330 | Phytother Res | Hepatic organic anion transporting polypeptides mediate disposition of milk thistle flavonolignans and pharmacokinetic silymarin-drug interactions. | 2021 | Details |
| A04525 | 33586811 | J Hum Nutr Diet | Association of dietary insulinaemic potential and odds of non-alcoholic fatty liver disease among adults: A case-control study. | 2021 | Details |
| A04526 | 33586673 | J Clin Invest | TREM2 sustains macrophage-hepatocyte metabolic coordination in nonalcoholic fatty liver disease and sepsis. | 2021 | Details |
| A04527 | 33586569 | Int J Food Sci Nutr | Reduced plasma carotenoids in individuals suffering from metabolic diseases with disturbances in lipid metabolism: a systematic review and meta-analysis of observational studies. | 2021 | Details |
| A04528 | 33586354 | ESC Heart Fail | Association of liver fibrosis risk scores with clinical outcomes in patients with heart failure with preserved ejection fraction: findings from TOPCAT. | 2021 | Details |
| A04529 | 33586159 | J Magn Reson Imaging | Automated Analysis of Multiparametric Magnetic Resonance Imaging/Magnetic Resonance Elastography Exams for Prediction of Nonalcoholic Steatohepatitis. | 2021 | Details |
| A04530 | 33586120 | Diabetes Ther | Empagliflozin Improves Liver Steatosis and Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. | 2021 | Details |
| A04531 | 33586025 | J Endocrinol Invest | Treatment potential of LPCN 1144 on liver health and metabolic regulation in a non-genomic, high fat diet induced NASH rabbit model. | 2021 | Details |
| A04532 | 33585266 | Front Cell Infect Microbiol | The Role of Porphyromonas gingivalis Outer Membrane Vesicles in Periodontal Disease and Related Systemic Diseases. | 2021 | Details |
| A04533 | 33585157 | Curr Hepatol Rep | Cardiovascular Disease in Nonalcoholic Steatohepatitis: Screening and Management. | 2020 | Details |
| A04534 | 33585009 | Gastroenterol Hepatol Bed Bench | Showing NAFLD, as a key connector disease between Alzheimer's disease and diabetes via analysis of systems biology. | 2020 | Details |
| A04535 | 33584988 | World J Hepatol | Shifting perspectives - interplay between non-alcoholic fatty liver disease and insulin resistance in lean individuals. | 2021 | Details |
| A04536 | 33584985 | World J Hepatol | New Year's greeting and overview of World Journal of Hepatology in 2021. | 2021 | Details |
| A04537 | 33584555 | Front Microbiol | The Therapeutic Efficacy of Curcumin vs. Metformin in Modulating the Gut Microbiota in NAFLD Rats: A Comparative Study. | 2021 | Details |
| A04538 | 33584545 | Front Endocrinol (Lausanne) | TLR9 in MAFLD and NASH: At the Intersection of Inflammation and Metabolism. | 2021 | Details |
| A04539 | 33584535 | Front Endocrinol (Lausanne) | Correlations Between MRI Biomarkers PDFF and cT1 With Histopathological Features of Non-Alcoholic Steatohepatitis. | 2021 | Details |
| A04540 | 33584144 | J Med Biochem | Study on the correlation between urinary retinol-binding protein and nonalcoholic fatty liver disease. | 2021 | Details |
| A04541 | 33584141 | J Med Biochem | Clinical relevance of lipid panel and aminotransferases in the context of hepatic steatosis and fibrosis as measured by transient elastography (FibroScan®). | 2021 | Details |
| A04542 | 33584134 | J Med Biochem | The role of oxidative stress in the development of obesity and obesity-related metabolic disorders. | 2021 | Details |
| A04543 | 33584072 | World J Gastroenterol | Histopathology and the predominantly progressive, indeterminate and predominately regressive score in hepatitis C virus patients after direct-acting antivirals therapy. | 2021 | Details |
| A04544 | 33584064 | World J Gastroenterol | Pleiotropy within gene variants associated with nonalcoholic fatty liver disease and traits of the hematopoietic system. | 2021 | Details |
| A04545 | 33583934 | J Epidemiol | Association between nutrient patterns and fatty liver index: Baseline survey of the Japan Multi-Institutional Collaborative Cohort Study in Tokushima, Japan. | 2021 | Details |
| A04546 | 33583577 | Clin Ther | Therapy for Nonalcoholic Fatty Liver Disease: Current Options and Future Directions. | 2021 | Details |
| A04547 | 33583033 | Eur J Clin Invest | Nonalcoholic fatty liver disease or metabolic dysfunction-associated fatty liver disease diagnoses and cardiovascular diseases: From epidemiology to drug approaches. | 2021 | Details |
| A04548 | 33582286 | Biochim Biophys Acta Mol Cell Biol Lipids | Chronic systemic exposure to IL6 leads to deregulation of glycolysis and fat accumulation in the zebrafish liver. | 2021 | Details |
| A04550 | 33581876 | Clin Ther | Noninvasive Evaluation for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. | 2021 | Details |
| A04552 | 33581653 | Biomed Pharmacother | Danthron ameliorates obesity and MAFLD through activating the interplay between PPARα/RXRα heterodimer and adiponectin receptor 2. | 2021 | Details |
| A04554 | 33581332 | Mitochondrion | Mitochondrial metabolism and calcium homeostasis in the development of NAFLD leading to hepatocellular carcinoma. | 2021 | Details |
| A04555 | 33581174 | J Hepatol | A structurally optimized FXR agonist, MET409, reduced liver fat content over 12 weeks in patients with non-alcoholic steatohepatitis. | 2021 | Details |
| A04556 | 33580876 | Curr Obes Rep | Efficacy of Dietary Manipulations for Depleting Intrahepatic Triglyceride Content: Implications for the Management of Non-alcoholic Fatty Liver Disease. | 2021 | Details |
| A04557 | 33580500 | J Food Sci | Major royal jelly proteins prevents NAFLD by improving mitochondrial function and lipid accumulation through activating the AMPK / SIRT3 pathway in vitro. | 2021 | Details |
| A04558 | 33580458 | Mol Biol Rep | Evaluating the effect of a mixture of two main conjugated linoleic acid isomers on hepatic steatosis in HepG2 cellular model. | 2021 | Details |
| A04559 | 33580453 | Hepatol Int | The epidemiology of NAFLD and lean NAFLD in Japan: a meta-analysis with individual and forecasting analysis, 1995-2040. | 2021 | Details |
| A04560 | 33580177 | Sci Rep | Nonalcoholic fatty liver disease and the risk of atrial fibrillation stratified by body mass index: a nationwide population-based study. | 2021 | Details |
| A04561 | 33579578 | J Ayurveda Integr Med | Elastographic liver evaluation of Katukyadi churna in the management of Non-Alcoholic Steatohepatitis (NASH) - A single arm clinical trial. | 2021 | Details |
| A04562 | 33579423 | Adv Cancer Res | NAFLD-related HCC. | 2021 | Details |
| A04563 | 33579000 | Int J Mol Sci | IL-6 Reduces Mitochondrial Replication, and IL-6 Receptors Reduce Chronic Inflammation in NAFLD and Type 2 Diabetes. | 2021 | Details |
| A04564 | 33578800 | Cancers (Basel) | Inflammatory Mechanisms Underlying Nonalcoholic Steatohepatitis and the Transition to Hepatocellular Carcinoma. | 2021 | Details |
| A04565 | 33578702 | Antioxidants (Basel) | Mechanisms of Non-Alcoholic Fatty Liver Disease in the Metabolic Syndrome. A Narrative Review. | 2021 | Details |
| A04566 | 33578624 | Medicine (Baltimore) | Gender-specific association between non-alcoholic fatty liver disease and type 2 diabetes mellitus among a middle-aged and elderly Chinese population: An observational study. | 2021 | Details |
| A04567 | 33578449 | Biotechnol Appl Biochem | An insight into the role of telmisartan as PPAR-γ/α dual activator in the management of nonalcoholic fatty liver disease. | 2021 | Details |
| A04568 | 33578292 | Biochem Biophys Res Commun | Mesenchymal stem cell-conditioned medium improved mitochondrial function and alleviated inflammation and apoptosis in non-alcoholic fatty liver disease by regulating SIRT1. | 2021 | Details |
| A04569 | 33577920 | J Hepatol | Diagnosis and management of secondary causes of steatohepatitis. | 2021 | Details |
| A04570 | 33577616 | PLoS One | Hepatorenal index for grading liver steatosis with concomitant fibrosis. | 2021 | Details |
| A04571 | 33577591 | PLoS Comput Biol | From heterogeneous healthcare data to disease-specific biomarker networks: A hierarchical Bayesian network approach. | 2021 | Details |
| A04572 | 33576570 | J Diabetes | The performance of noninvasive indexes of adults in identification of nonalcoholic fatty liver disease in children. | 2021 | Details |
| A04573 | 33576035 | Hepatology | Cordycepin Ameliorates Nonalcoholic Steatohepatitis by Activation of the AMP-Activated Protein Kinase Signaling Pathway. | 2021 | Details |
| A04574 | 33575290 | Hepatobiliary Surg Nutr | Hepatocellular carcinoma in non-alcoholic fatty liver disease-a review of an emerging challenge facing clinicians. | 2021 | Details |
| A04575 | 33574841 | Int J Endocrinol | Evaluation of Different Anthropometric Indicators for Screening for Nonalcoholic Fatty Liver Disease in Elderly Individuals. | 2021 | Details |
| A04576 | 33574823 | Front Immunol | Self-Nucleic Acid Sensing: A Novel Crucial Pathway Involved in Obesity-Mediated Metaflammation and Metabolic Syndrome. | 2021 | Details |
| A04577 | 33574818 | Front Immunol | Predicting Non-Alcoholic Fatty Liver Disease Progression and Immune Deregulations by Specific Gene Expression Patterns. | 2021 | Details |
| A04578 | 33574817 | Front Immunol | Epigenetic Regulation of Kupffer Cell Function in Health and Disease. | 2021 | Details |
| A04579 | 33574380 | Sci Rep | MUTYH is associated with hepatocarcinogenesis in a non-alcoholic steatohepatitis mouse model. | 2021 | Details |
| A04580 | 33573891 | J Diabetes Complications | Importance of non-invasive liver fibrosis scores for mortality and complications development in individuals with type 2 diabetes. | 2021 | Details |
| A04581 | 33573745 | J Am Coll Cardiol | Leptin in Leanness and Obesity: JACC State-of-the-Art Review. | 2021 | Details |
| A04582 | 33573415 | Ecol Food Nutr | Food Insecurity and Lipid Profile Abnormalities Are Associated with an Increased Risk of Nonalcoholic Fatty Liver Disease (NAFLD): A Case-Control Study. | 2021 | Details |
| A04583 | 33573385 | Rev Esp Enferm Dig | Looking for a new name for non-alcoholic fatty liver disease in Spanish: esteatosis hepática metabólica (EHmet). | 2021 | Details |
| A04584 | 33572810 | Nutrients | Krill Oil Supplementation Reduces Exacerbated Hepatic Steatosis Induced by Thermoneutral Housing in Mice with Diet-Induced Obesity. | 2021 | Details |
| A04585 | 33572797 | Cancers (Basel) | The Current View of Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma. | 2021 | Details |
| A04586 | 33572544 | J Clin Med | Renaming NAFLD to MAFLD: Could the LDE System Assist in This Transition? | 2021 | Details |
| A04587 | 33572481 | J Clin Med | Cognitive Dysfunction in Non-Alcoholic Fatty Liver Disease-Current Knowledge, Mechanisms and Perspectives. | 2021 | Details |
| A04588 | 33572376 | J Clin Med | Non-Alcoholic Fatty Liver in Patients with Chylomicronemia. | 2021 | Details |
| A04589 | 33572340 | Healthcare (Basel) | Impact of Nutrition Care Process Documentation in Obese Children and Adolescents with Metabolic Syndrome and/or Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A04590 | 33571553 | J Hepatol | Magnesium accumulation upon cyclin M4 silencing activates microsomal triglyceride transfer protein improving NASH. | 2021 | Details |
| A04591 | 33571540 | Metabolism | The S100 calcium-binding protein A11 promotes hepatic steatosis through RAGE-mediated AKT-mTOR signaling. | 2021 | Details |
| A04592 | 33570858 | Clin Transl Gastroenterol | Positive Fecal Immunochemical Test Strongly Predicts Adenomas in Younger Adults With Fatty Liver and Metabolic Syndrome. | 2021 | Details |
| A04593 | 33570776 | Hepatology | A Machine Learning Approach Enables Quantitative Measurement of Liver Histology and Disease Monitoring in NASH. | 2021 | Details |
| A04594 | 33569991 | Arch Physiol Biochem | The potential of Artemisia species for use as broad-spectrum agents in the management of metabolic syndrome: a review. | 2021 | Details |
| A04595 | 33569851 | J Gastroenterol Hepatol | Simple non-invasive scoring systems and histological scores in predicting mortality in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis. | 2021 | Details |
| A04596 | 33569476 | Ann Transl Med | A narrative review of the roles of indoleamine 2,3-dioxygenase and tryptophan-2,3-dioxygenase in liver diseases. | 2021 | Details |
| A04597 | 33568925 | Diabetes Metab Syndr Obes | The Impact of Vitamin D in Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study in Patients with Morbid Obesity. | 2021 | Details |
| A04598 | 33568794 | Nat Rev Gastroenterol Hepatol | Therapeutic pipeline in nonalcoholic steatohepatitis. | 2021 | Details |